Cell Therapeut. was ist los? - 500 Beiträge pro Seite

[elica]

hallo

ich sehe gerade bei L&S Bid:32,34 ASK:33.94

hat jemand irgentwelche Nachrichten oder faengt hier
das gleich an wie bei Celgene?

elica

[hansinluck]

|||||||||| Biotech Report
|
|
Cell Therapeutics loss exceeds views
Executives seen upbeat about 2001 sales of cancer drug


By Stephanie O`Brien, CBS.MarketWatch.com
Last Update: 3:31 PM ET Feb 15, 2001

Newswatch
Latest Headlines
Get Alerted


NEW YORK (CBS.MW) -- Shares of Cell Therapeutics fell after the company posted a wider-than-expected fourth-quarter loss.
Even though company executives were upbeat about 2001 sales of a recently launched cancer drug, shares were down $1.50, or about 4.4 percent, to $32.50 in recent trading.



Cell Therapeutics (CTIC: news, msgs) said it lost $15.2 million, or 47 cents a share, compared to the loss of $13.5 million, or 87 cents in the same quarter a year earlier. Cell Therapeutics had roughly double the number of average shares outstanding in the latest quarter compared to the 1999 period.

Wall Street had expected Cell Therapeutics to lose 35 cents in the most recent quarter, according to First Call/Thomson Financial`s survey of three analysts. Cell Therapeutics generated $502,000 in product sales in the period, its first revenues.

Wells Fargo Van Kasper analyst Alan Auerbach downplayed the size of the quarterly loss. He said higher research-and-development costs and increased sales-and-marketing expenses associated with the fourth-quarter launch of the cancer drug Trisenox contributed to it.

Auerbach also said that on a conference call Thursday, Cell Therapeutics executives told analysts they expect to exceed the current 2001 sales estimate of $6.4 million for Trisenox.

He said he expects the oncology products company to be profitable in 2004.

[joeiffi]

CTIC ist unter die Stop-Marke von 35 Euro gefallen. Bitte gebt mir einen Rat ob ich heute noch verkaufen soll oder nach dem Motto "Augen zu und durch" halten.

[Mr. Salami]

Eine Meinung aus dem Yahoo-Board, der ich anschließe:

- Rev. forecasts for 2001 have been raised.
- Lots and lots of Trisonex and PG-TXL data to be featured/presented in May.
- Janus and Invesco are now huge investors
- Lindsay Rosenwald keeps buying and buying and buying
- Unlike the beer drinking Mo, Analyst just love the smooth-talking, Wine-sipping, Dr. Bianco.
- tons of cash in bank
- more and more analysts should be jumping on board shortly, expecially since we are now part of the Naz-biotech index

Also, halten/nachkaufen wenn Du kannst.

So long
Mr. Salami